1. Coronavirus: EU says it struck deal with Sanofi for 300 million doses of potential COVID-19 vaccine  euronews (in English)
  2. Sanofi, GlaxoSmithKline snag biggest coronavirus vaccine deal yet  ABS-CBN News
  3. US promises $2.1 billion for Sanofi, GSK coronavirus vaccine  INQUIRER.net
  4. Sanofi, Glaxo advance talks to supply up to 300M COVID-19 vaccine doses to Europe - companies  GMA News
  5. EU reserves 300 million doses of potential Sanofi virus vaccine  ABS-CBN News
  6. View Full coverage on Google News
Sanofi-GSK deal is for 100 million doses, at two per person, and gives the govt an option to purchase an additional 500m doses.Sanofi-GSK deal is for 100 million doses, at two per person, and gives the govt an option to purchase an additional 500m doses.

US to pay $2.1bn to Sanofi, GSK in Covid-19 vaccine deal - Newspaper - DAWN.COM

Bloomberg - Are you a robot?

Executives with pharma ties are exempt from disclosing conflicts.

Vaccine project contract raises transparency questions - POLITICO

The head of the government’s effort to develop a vaccine against Covid-19 says he expects the vaccine to have efficacy rates “in the 90%” range — but that there might not be enough vaccines available for all Americans until the end of next year. “I think it will be a very effective vaccine. That’s my […]The head of the government’s effort to develop a vaccine against Covid-19 says he expects the vaccine to have efficacy rates “in the 90%” range — but that there might not be…

Operation Warp Speed leader predicts effectiveness of coronavirus vaccine to be ‘in the 90%’ range | KTLA

The head of the government’s effort to develop a vaccine against Covid-19 says he expects the vaccine to have efficacy rates “in the 90%” range — but that there might not be…

Operation Warp Speed leader predicts effectiveness of coronavirus vaccine to be ‘in the 90%’ range | KTLA

"You can't have a contractor supervising government officials.""You can't have a contractor supervising government officials."

Trump's Vaccine Chief Picks His Own Former Employer—Where He Still Holds Millions Worth of Stock—for $2.1 Billion Deal | Common Dreams News

EU reserves 300 mn doses of potential Sanofi virus vaccineEU reserves 300 mn doses of potential Sanofi virus vaccine

EU reserves 300 mn doses of potential Sanofi virus vaccine - France 24

The European Union has reached an agreement with French pharmaceutical giant Sanofi for the supply of 300 million doses of a potential coronavirus vaccine.The European Union has reached an agreement with French pharmaceutical giant Sanofi for the supply of 300 million doses of a potential coronavirus vaccine.

EU strikes deal with Sanofi for supply of potential COVID-19 vaccine | News | DW | 01.08.2020

Several coronavirus vaccine trials have reached the final Phase 3 stage of testing ahead of potential approvals from regulators. Researchers are targeting efficacy of at least 60% for the drugs, according to Dr. Anthony Fauci, which is the standard for vaccines.Several coronavirus vaccine trials have reached the final Phase 3 stage of testing ahead of potential approvals from regulators. Researchers are targeting efficacy of at least 60% for the drugs, ac…

This might be the best coronavirus vaccine news you’ve ever heard – BGR

Moncef Slaoui, head of the government's effort to develop a vaccine against Covid-19, says he expects the vaccine to have efficacy rates "in the 90%" range -- but that there might not be enough vaccine available for all Americans until the end of next year.

Vaccine: Operation Warp Speed leader expects coronavirus drug to be highly effective

Sanofi to set aside 300 million doses of potential coronavirus vaccine for 27 EU membersThe European Union announced Friday that it had struck a deal with French pharmaceutical giant Sanofi for 300 million doses of a potential coronavirus vaccine. The European...

Sanofi to set aside 300 million doses of potential coronavirus vaccine for 27 EU members | Daily Sabah

The arrangement brings the Trump administration’s investment in coronavirus vaccine projects to more than $8 billion. The head of the federal effort is a former GSK executive.The arrangement brings the Trump administration’s investment in coronavirus vaccine projects to more than $8 billion. The head of the federal effort is a former GSK executive.

You have been blocked

The EU announced Friday that it had struck a deal with French pharmaceutical giant Sanofi for 300 million doses of a potential coronavirus vaccine. The EU announced Friday that it had struck a deal with French pharmaceutical giant Sanofi for 300 million doses of a potential coronavirus vaccine.

EU reserves 300 million doses of potential Sanofi virus vaccine | ABS-CBN News

The Commission said the aim of the talks with Sanofi was to clinch an advance purchase deal.The Commission said the aim of the talks with Sanofi was to clinch an advance purchase deal.

EU in talks to secure Sanofi deal for coronavirus vaccine - Moneycontrol.com

(Reuters) - Two major drug companies will supply the U.S. government with 100 million doses of an experimental coronavirus vaccine, the Trump administration said on Friday, as the nation's top health agency predicted that fatalities would rise in the coming weeks.(Reuters) - Two major drug companies will supply the U.S. government with 100 million doses of an experimental coronavirus vaccine, the Trump administration said on Friday, as the nation's top health agency predicted that fatalities would rise in the coming weeks.

U.S. makes deal for 100 million doses of coronavirus vaccine, deaths expected to rise | The Star

Pharma giants GlaxoSmithKline and Sanofi Pasteur will supply 100 million doses of potential COVID-19 vaccine to the US.Pharma giants GlaxoSmithKline and Sanofi Pasteur will supply 100 million doses of potential COVID-19 vaccine to the US.

US to sink up to another $2.1bn for potential COVID-19 vaccine | Coronavirus pandemic News | Al Jazeera

The U.S. government is supporting development and manufacturing of the coronavirus vaccine in exchange for 100 million doses.The U.S. government is supporting development and manufacturing of the coronavirus vaccine in exchange for 100 million doses.

Sanofi and GlaxoSmithKline Snag a $2.1 Billion Contract for Their Coronavirus Vaccine | The Motley Fool

The head of the government's effort to develop a vaccine against COVID-19 says he expects the vaccine to have efficacy rates "in the 90%" range — but that there might not be enough vaccine available for all Americans until the end of next year.The head of the government's effort to develop a vaccine against COVID-19 says he expects the vaccine to have efficacy rates "in the 90%" range — but that there might not be enough vaccine available for all Americans until the end of next year.

Operation Warp Speed leader says he expects virus vaccine to be highly effective, 'in the 90%' range

Sanofi recently moved up the date of its first clinical trial to September. Companies like Moderna's have already reached phase 3.Sanofi recently moved up the date of its first clinical trial to September. Companies like Moderna's have already reached phase 3.

Sanofi GSK coronavirus vaccine gets funded by Operation Warp Speed - Business Insider

The US government will provide drugmakers GlaxoSmithKline (GSK) and Sanofi $2.1 billion for the production of COVID-19 vaccines for up to 50 million people, the...The US government will provide drugmakers GlaxoSmithKline (GSK) and Sanofi $2.1 billion for the production of COVID-19 vaccines for up to 50 million people, the...

US Pledges $2.1 Billion to Two Drugmakers in Biggest Grant Yet for COVID-19 Vaccine - Sputnik International

Two major drug companies will supply the U.S. government with 100 million doses of an experimental coronavirus vaccine, the Trump administration said on Friday, as the nation's top health agency predicted that fatalities would rise in the coming weeks.Two major drug companies will supply the U.S. government with 100 million doses of an experimental coronavirus vaccine, the Trump administration said on Friday, as the nation's top health agency predicted that fatalities would rise in the coming weeks.

COVID-19 Vaccine: US Makes Deal For 100 Million Doses Of COVID-19 Vaccine, Deaths Expected To Rise

The U.S. award is the biggest yet from 'Operation Warp Speed', the White House initiative aimed at accelerating access to vaccines and treatments to fight COVID-19, the respiratory disease caused by the novel coronavirusThe Sanofi-GSK deal is for 100 million doses, at two per person, and gives the U.S. government an option to purchase an additional 500 million doses at an unspecified price

Biggest COVID-19 vaccine deal yet; Sanofi, GSK sign $2.1 billion deal with US govt

Pharma giants Sanofi and GSK will receive up to $2.1 billion from the US government for the development of a COVID-19 vaccine, the companies said Friday, as the world continues to be ravaged by the coronavirus ...

US to put up $2.1 bn for Sanofi, GSK coronavirus vaccine

The EU announced Friday that it had struck a deal with French pharmaceutical giant Sanofi for 300 million doses of a potential coronavirus vaccine.The EU announced Friday that it had struck a deal with French pharmaceutical giant Sanofi for 300 million doses of a potential coronavirus vaccine.

Sanofi, GSK reach COVID-19 vaccine deals with US, EU - CNA

LONDON (AP) — Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of its experimental COVID-19vaccine to the United States as governments buy up supplies in hopes of securing a candidate that works. The United States will pay up to $2. 1 billion "for development including clinical trials, manufacturing, scale-up and delivery" of the vaccine, the two companies based in Europe said in a statement. Sanofi will get the bulk of the funds. The U. S.LONDON (AP) — Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of its experimental COVID-19vaccine to the United States as governments buy up supplies in hopes of securing a candidate that works. The United States will pay up to $2. 1 billion "for development including clinical trials, manufacturing, scale-up and delivery" of the vaccine, the two companies based in Europe said in a statement. Sanofi will get the bulk of the funds. The U. S.

US sinks another $2.1 billion into a potential vaccine | KECI

US sinks another $2.1 billion into a potential vaccine

The deal appears to price the vaccine at less than $10.50 a dose.The deal appears to price the vaccine at less than $10.50 a dose.

Glaxo and Sanofi Will Sell 100 Million Covid-19 Vaccine Doses to the U.S. - Barron's

The United States has agreed a $2.1bn (£1.6bn) deal with two big pharmaceutical companies to produce 100 million doses of an experimental Covid-19 vaccine. British pharmaceutical giant GlaxoSmithKline and French counterpart Sanofi Pasteur announced the agreement with the US government on Friday.  The deal is believed to be the largest such agreement to date, as countries startThe United States has agreed a $2.1bn (£1.6bn) deal with two big pharmaceutical companies to produce 100 million doses of an experimental Covid-19 vaccine. British pharmaceutical giant

Coronavirus vaccine: US seals $2.1bn deal with drug companies for 100 million doses | The Independent

Drug giants GlaxoSmithKline and Sanofi Pasteur said Friday they had won a commitment from the U.S. federal government to pay up to $2.1 billion to help the two companies move forward with their proposed joint coronavirus vaccine as part of Operation Warp Speed.Drug giants GlaxoSmithKline and Sanofi Pasteur said Friday they had won a commitment from the U.S. federal government to pay up to $2.1 billion to help the two companies move forward with their proposed joint coronavirus vaccine as part of Operation Warp Speed.

Two drug giants to partner on US$2B coronavirus vaccine contract | CTV News

404 Not Found

The U.S. will pay up to $2.1 billion to Sanofi and GlaxoSmithKline to fund the development of a coronavirus vaccine and guarantee supply of 100 million doses, if proven safe and effective in clinical trials, the companies said.The U.S. will pay up to $2.1 billion to Sanofi and GlaxoSmithKline to fund the development of a coronavirus vaccine and guarantee supply of 100 million doses, if proven safe and effective in clinical trials, the companies said.

Sanofi, GlaxoSmithKline Ink Coronavirus Vaccine Deal With U.S. - WSJ

If the data is positive, both manufacturers could produce up to 1 billion doses per year.

RTL Today - Coronavirus vaccine: Sanofi, GSK reach virus vaccine deals with US, EU

Insiders from at least 11 companies working on COVID research have sold shares worth more than $1 billion since March.Insiders from at least 11 companies working on COVID research have sold shares worth more than $1 billion since March.

Who Profits From Trump Administration's $6 Billion Vaccine Program?

The feds will give Sanofi and GlaxoSmithKline up to $2.1 billion to churn out a coronavirus vaccine in the Trump administration's latest and largest bet on an experimental inoculation.The feds will give Sanofi and GlaxoSmithKline up to $2.1 billion to churn out a coronavirus vaccine in the Trump administration’s latest and largest bet on an experimental inoculation. More than

US pledges $2.1B to COVID vaccine from Sanofi, GlaxoSmithKline

The first wave of coronavirus vaccines might be like a flu shot, experts say, curbing the worst symptoms in some patients but not entirely preventing them from getting COVID-19.The first wave of coronavirus vaccines might be like a flu shot, experts say, curbing symptoms in some patients but not protecting them from COVID-19.

Coronavirus vaccines are in the works, but keep your mask - Los Angeles Times

The deal contracts Sanofi and GlaxoKlineSmith to provide the US with enough doses of their vaccine to inoculate 50 million Americans at a price of about $42 per person - if it is effective.The deal contracts Sanofi and GlaxoKlineSmith to provide the US with enough doses of their vaccine to inoculate 50 million Americans at a price of about $42 per person - if it is effective.

US signs $2.1billion deal for 100 million doses of Sanofi, GSK vaccine | Daily Mail Online

Sanofi, already working with BARDA on a GlaxoSmithKline-partnered COVID-19 vaccine, has won further support from the U.S. government—this time, to the tune of $2.1 billion for clinical development and delivery of 100 million doses. It's a hefty bet, but on a proven vaccine technology from two of the biggest vaccine makers in the business.Sanofi, already working with BARDA on a GlaxoSmithKline-partnered COVID-19 vaccine, has won further support from the U.S. government—this time, to the tune of $2.1 billion for clinical development and delivery of 100 million doses. It's a hefty bet, but on a proven vaccine technology from two of the biggest vaccine makers in the business.

Top vaccine players Sanofi, GSK win $2.1B Warp Speed funding for COVID-19 shot | FiercePharma

News, analysis and comment from the Financial Times, the worldʼs leading global business publication

Subscribe to read | Financial Times

Operation Warp Speed will provide up to $2.1 billion to Sanofi and GlaxoSmithKline to fund development and manufacturing of the companies' Covid-19 vaccine.Operation Warp Speed will provide up to $2.1 billion to Sanofi and GlaxoSmithKline to fund development and manufacturing of the companies' Covid-19 vaccine.

U.S. to pay Sanofi and GSK $2.1 billion for Covid-19 vaccine - STAT

This is the country’s biggest Covid-19 vaccine deal yet.This is the country’s biggest Covid-19 vaccine deal yet.

U.S. To Spend $2.1 Billion On GlaxoSmithKline-Sanofi Covid-19 Vaccine

Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.

Recon: Moderna eyes $50-60 price for COVID-19 vaccine; UK signs deal for Sanofi, GSK coronavirus vac | RAPS